 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 May 1995 | Volume 122 Issue 10 | Pages 778-788
Purpose: To review the literature on the long-term health effects of exposure to diethylstilbestrol (DES) among women prescribed DES during pregnancy (DES mothers), among their children exposed in utero to the drug (DES sons and daughters) and among the progeny of these exposed sons and daughters (DES grandchildren).
Data Sources: English-language articles were identified through MEDLINE and CANCERLIT searches and through review of the bibliographies of identified articles.
Study Selection: All human studies relevant to long-term health effects of exposure to DES were reviewed.
Data Extraction: Descriptive data on existing DES cohorts were extracted from early publications. Risk estimates for health effects were extracted from published reports.
Data Synthesis: An estimated 5 to 10 million Americans received DES during pregnancy or were exposed to the drug in utero. Exposure to DES has been associated with an increased risk for breast cancer in DES mothers (relative risk, <2.0) and with a lifetime risk of clear-cell cervicovaginal cancer in DES daughters of 1/1000 to 1/10 000. The association between DES exposure and testicular cancer in DES sons remains controversial. Exposure to DES has also been linked to reproductive tract abnormalities in DES sons and daughters that consist of immune system disorders and psychosexual effects. No evidence for transgenerational effects currently exists. Recommendations for screening persons exposed to DES are reviewed.
Conclusions: Further research is needed to define long-term health effects related to DES exposure. Such research would provide a basis for counseling persons exposed to DES and would further understanding of environmental and pharmacologic compounds similar to DES.
Author and Article Information
From the National Cancer Institute, Bethesda, Maryland.
REVIEW
Diethylstilbestrol Revisited: A Review of the Long-Term Health Effects
Requests for Reprints: Ruthann M. Giusti, MD, Office of the Director, Division of Cancer Treatment, Building 31, Room 3A44, National Cancer Institute, Bethesda, MD 20892-2440.
Acknowledgments: The authors thank Elizabeth Anderson, PhD; the National Institutes of Health DES Working Group (Florence Haseltine, MD; Suzanne Haynes, PhD; Robert Hoover, MD; Judith LaRosa, PhD; John McLachlan, PhD; Maria Merino, MD; G. Iris Obrams, MD, PhD; Iris Schneider; Susan Sieber, PhD; Kevin Tonat; Rosemary Torres, Esq; and Edward Trimble, MD); Paticia Hartge, ScD, for her helpful comments; and T. Timothy Chen, PhD, for statistical assistance.
This article has been cited by other articles:
|
|
 |
|
  W. H James Evidence that mammalian sex ratios at birth are partially controlled by parental hormone levels around the time of conception J. Endocrinol., July 1, 2008; 198(1): 3 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Gore Why Endocrinologists Need to Take Ownership of Endocrine Disruption Experimental Biology and Medicine, January 1, 2008; 233(1): 3 - 3. [Full Text] [PDF]
|
|
|
|
 |
|
 S. DE ASSIS and L. HILAKIVI-CLARKE Timing of Dietary Estrogenic Exposures and Breast Cancer Risk Ann. N.Y. Acad. Sci., November 1, 2006; 1089(1): 14 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Titus-Ernstoff, R. Troisi, E. E Hatch, L. A Wise, J. Palmer, M. Hyer, R. Kaufman, E. Adam, W. Strohsnitter, K. Noller, et al. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES) Int. J. Epidemiol., August 1, 2006; 35(4): 862 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Anway and M. K. Skinner Epigenetic Transgenerational Actions of Endocrine Disruptors Endocrinology, June 1, 2006; 147(6): s43 - s49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. V. Henley and K. S. Korach Endocrine-Disrupting Chemicals Use Distinct Mechanisms of Action to Modulate Endocrine System Function Endocrinology, June 1, 2006; 147(6): s25 - s32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Newbold, E. Padilla-Banks, and W. N. Jefferson Adverse Effects of the Model Environmental Estrogen Diethylstilbestrol Are Transmitted to Subsequent Generations Endocrinology, June 1, 2006; 147(6): s11 - s17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.M. Brouwers, W.F.J. Feitz, L.A.J. Roelofs, L.A.L.M. Kiemeney, R.P.E. de Gier, and N. Roeleveld Hypospadias: a transgenerational effect of diethylstilbestrol? Hum. Reprod., March 1, 2006; 21(3): 666 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Roger, S Lambard, A Bouskine, B Mograbi, D Chevallier, M Nebout, G Pointis, S Carreau, and P Fenichel Estrogen-induced growth inhibition of human seminoma cells expressing estrogen receptor {beta} and aromatase J. Mol. Endocrinol., August 1, 2005; 35(1): 191 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zaleska, A. Waclawik, G. Bodek, A. Zezula-Szpyra, X. Li, T. Janowski, W. H. Hansel, N. A. Rahman, and A. J. Ziecik Growth Repression in Diethylstilbestrol/Dimethylbenz[a]anthracene-Induced Rat Mammary Gland Tumor Using Hecate-CG{beta} Conjugate Experimental Biology and Medicine, April 1, 2004; 229(4): 335 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kurita, A. A. Mills, and G. R. Cunha Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis Development, April 1, 2004; 131(7): 1639 - 1649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Goldman, H. Falk, P. J. Landrigan, S. J. Balk, J. R. Reigart, and R. A. Etzel Environmental Pediatrics and Its Impact on Government Health Policy Pediatrics, April 1, 2004; 113(4/S1): 1146 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Manikkam, E. J. Crespi, D. D. Doop, C. Herkimer, J. S. Lee, S. Yu, M. B. Brown, D. L. Foster, and V. Padmanabhan Fetal Programming: Prenatal Testosterone Excess Leads to Fetal Growth Retardation and Postnatal Catch-Up Growth in Sheep Endocrinology, February 1, 2004; 145(2): 790 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Rosa-e-Silva, M. A. Guimaraes, V. Padmanabhan, and H. E. Lara Prepubertal Administration of Estradiol Valerate Disrupts Cyclicity and Leads to Cystic Ovarian Morphology during Adult Life in the Rat: Role of Sympathetic Innervation Endocrinology, October 1, 2003; 144(10): 4289 - 4297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Do, S. Ryu, M. Nagarkatti, and P. S. Nagarkatti Role of Death Receptor Pathway in Estradiol-Induced T-Cell Apoptosis in Vivo Toxicol. Sci., November 1, 2002; 70(1): 63 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Joffe Myths about endocrine disruption and the male reproductive system should not be propagated Hum. Reprod., February 1, 2002; 17(2): 520 - 521. [Full Text] [PDF]
|
|
|
|
|
|
K.A. Thayer, R.L. Ruhlen, K.L. Howdeshell, D.L. Buchanan, P.S. Cooke, D. Preziosi, W.V. Welshons, J. Haseman, and F.S. vom Saal Altered prostate growth and daily sperm production in male mice exposed prenatally to subclinical doses of 17{{alpha}}-ethinyl oestradiol Hum. Reprod., May 1, 2001; 16(5): 988 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Solomon and T. Schettler Environment and health: 6. Endocrine disruption and potential human health implications Can. Med. Assoc. J., November 1, 2000; 163(11): 1471 - 1476. [Full Text] [PDF]
|
|
|
|
|
|
C. Gupta Reproductive Malformation of the Male Offspring Following Maternal Exposure to Estrogenic Chemicals Experimental Biology and Medicine, June 1, 2000; 224(2): 61 - 68. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Iguchi and T. Sato Endocrine Disruption and Developmental Abnormalities of Female Reproduction Integr. Comp. Biol., June 1, 2000; 40(3): 402 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Duke, S. A. McGraw, and N. E. Avis Exposure to Diethylstilbestrol: Design of a Multilevel Community Intervention Health Promot Pract, April 1, 2000; 1(2): 188 - 195. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Takeyama, T. Suzuki, G. Hirasawa, Y. Muramatsu, H. Nagura, K. Iinuma, J. Nakamura, K.-i. Kimura, M. Yoshihama, N. Harada, et al. 17{beta}-Hydroxysteroid Dehydrogenase Type 1 and 2 Expression in the Human Fetus J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 410 - 416. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. E. Hatch, J. R. Palmer, L. Titus-Ernstoff, K. L. Noller, R. H. Kaufman, R. Mittendorf, S. J. Robboy, M. Hyer, C. M. Cowan, E. Adam, et al. Cancer Risk in Women Exposed to Diethylstilbestrol In Utero JAMA, August 19, 1998; 280(7): 630 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Feldman M.D. Editorial: Estrogens from Plastic--Are We Being Exposed? Endocrinology, May 1, 1997; 138(5): 1777 - 1779. [Full Text] [PDF]
|
|
|
|
 |
|
 Pre-conception, pregnancy and prescribing DTB, April 1, 1996; 34(4): 25 - 27. [Abstract] [Full Text] [PDF]
|
|
Article
